Related references
Note: Only part of the references are listed.Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration
K. O. Kagan et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2019)
Breakthrough cytomegalovirus pneumonia in hematopoietic stem cell transplant recipient on letermovir prophylaxis
Bettina M. Knoll et al.
BONE MARROW TRANSPLANTATION (2019)
Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
Chien-Ting Lin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Real-Time Visualization and Quantification of Human Cytomegalovirus Replication in Living Cells Using the ANCHOR DNA Labeling Technology
Bernard Mariame et al.
JOURNAL OF VIROLOGY (2018)
Expression Levels of Glycoprotein O (gO) Vary between Strains of Human Cytomegalovirus, Influencing the Assembly of gH/gL Complexes and Virion Infectivity
Le Zhang et al.
JOURNAL OF VIROLOGY (2018)
Letermovir for the prevention of cytomegalovirus infection in adult cytomegalovirus-seropositive hematopoietic stem cell transplant recipients
Farnaz Foolad et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2018)
Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection
Lauren Cherrier et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation
Kaiwen Chen et al.
BLOOD ADVANCES (2018)
Pharmacokinetics and Exposure-Response Analysis of RG7667, a Combination of Two Anticytomegalovirus Monoclonal Antibodies, in a Phase 2a Randomized Trial To Prevent Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients
Rong Deng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients
Julie H. Ishida et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial
Takehiko Mori et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells
Xiaohong Cui et al.
JOURNAL OF VIROLOGY (2017)
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
F. M. Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The role of immunoglobulin prophylaxis for prevention of cytomegalovirus infection in pediatric hematopoietic stem cell transplantation recipients
Gal Goldstein et al.
PEDIATRIC BLOOD & CANCER (2017)
Congenital cytomegalovirus infection undermines early development and functions of the human placenta
Lenore Pereira et al.
PLACENTA (2017)
Human cytomegalovirus glycoprotein complex gH/gL/gO uses PDGFR-α as a key for entry
Yiquan Wu et al.
PLOS PATHOGENS (2017)
The clinical impact of cytomegalovirus infection following allogeneic hematopoietic cell transplantation: Why the quest for meaningful prophylaxis still matters
Shawna T. Chan et al.
BLOOD REVIEWS (2017)
Risk Factors and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infection in Solid Organ Transplant Recipients
Cynthia E. Fisher et al.
CLINICAL INFECTIOUS DISEASES (2017)
Cytomegalovirus Virions Shed in Urine Have a Reversible Block to Epithelial Cell Entry and Are Highly Resistant to Antibody Neutralization
Xiaohong Cui et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Characterization of Cytomegalovirus Breakthrough Events in a Phase 2 Prophylaxis Trial of Letermovir (AIC246, MK 8228)
Peter Lischka et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Viral Regulation of Cell Tropism in Human Cytomegalovirus
Gang Li et al.
JOURNAL OF VIROLOGY (2016)
Cytomegalovirus latency and reactivation: recent insights into an age old problem
Liane Dupont et al.
REVIEWS IN MEDICAL VIROLOGY (2016)
A First-in-Human Study To Assess the Safety and Pharmacokinetics of Monoclonal Antibodies against Human Cytomegalovirus in Healthy Volunteers
Kiran Dole et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
In Vitro Characterization of Human Cytomegalovirus-Targeting Therapeutic Monoclonal Antibodies LJP538 and LJP539
Hetalkumar D. Patel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Maternal Antibody Responses and Nonprimary Congenital Cytomegalovirus Infection of HIV-1-Exposed Infants
Kristy M. Bialas et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Preclinical evaluations of peptide-conjugate vaccines targeting the antigenic domain-2 of glycoprotein B of human cytomegalovirus
Adam C. Finnefrock et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer
Anna Kabanova et al.
NATURE MICROBIOLOGY (2016)
CMV in Hematopoietic Stem Cell Transplantation
Rafael de la Camara
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2016)
Valganciclovir for the Prevention of Complications of Late Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation A Randomized Trial
Michael Boeckh et al.
ANNALS OF INTERNAL MEDICINE (2015)
Rapid In Vitro Evolution of Human Cytomegalovirus UL56 Mutations That Confer Letermovir Resistance
Sunwen Chou
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Human Cytomegalovirus gH/gL/gO Promotes the Fusion Step of Entry into All Cell Types, whereas gH/gL/UL128-131 Broadens Virus Tropism through a Distinct Mechanism
Momei Zhou et al.
JOURNAL OF VIROLOGY (2015)
A High-Affinity Native Human Antibody Neutralizes Human Cytomegalovirus Infection of Diverse Cell Types
Lawrence M. Kauvar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
The immunological underpinnings of vaccinations to prevent cytomegalovirus disease
A. Louise McCormick et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Geno- and Phenotypic Characterization of Human Cytomegalovirus Mutants Selected In Vitro after Letermovir (AIC246) Exposure
Thomas Goldner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Human Responses to Influenza Vaccination Show Seroconversion Signatures and Convergent Antibody Rearrangements
Katherine J. L. Jackson et al.
CELL HOST & MICROBE (2014)
Role of of human cytomegalovirus (HCMV)-specific antibody in HCMV-infected pregnant women
Maria Grazia Revello et al.
EARLY HUMAN DEVELOPMENT (2014)
Maternal, Fetal, and Neonatal Parameters for Prognosis and Counseling of HCMV Congenital Infection
Maurizio Zavattoni et al.
JOURNAL OF MEDICAL VIROLOGY (2014)
A new look at a poorly immunogenic neutralization epitope on cytomegalovirus glycoprotein B. Is there cause for antigen redesign?
Mats Ohlin
MOLECULAR IMMUNOLOGY (2014)
Multiplexed screening of natural humoral immunity identifies antibodies at fine specificity for complex and dynamic viral targets
Krista M. McCutcheon et al.
MABS (2014)
A Randomized Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus
Maria Grazia Revello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Hyperimmune Globulin to Prevent Congenital CMV Infection
Klaus Hamprecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Incidence and Impact of CMV Infection in Very Low Birth Weight Infants
Kristen M. Turner et al.
PEDIATRICS (2014)
Isolation of Highly Suppressive CD25+FoxP3+T Regulatory Cells from G-CSF-Mobilized Donors with Retention of Cytotoxic Anti-Viral CTLs: Application for Multi-Functional Immunotherapy Post Stem Cell Transplantation
Edward R. Samuel et al.
PLOS ONE (2014)
Genomic and Functional Characteristics of Human Cytomegalovirus Revealed by Next-Generation Sequencing
Steven Sijmons et al.
VIRUSES-BASEL (2014)
Convergent Antibody Signatures in Human Dengue
Poornima Parameswaran et al.
CELL HOST & MICROBE (2013)
Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine
Daniel C. Freed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation
Camille N. Kotton et al.
TRANSPLANTATION (2013)
Human T cell aging and the impact of persistent viral infections
T. Fueloep et al.
FRONTIERS IN IMMUNOLOGY (2013)
Cytomegalovirus Impairs Cytotrophoblast-Induced Lymphangiogenesis and Vascular Remodeling in an in Vivo Human Placentation Model
Takako Tabata et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Primary Maternal Cytomegalovirus Infection During Pregnancy: Do We Have a Treatment Option?
Stuart P. Adler
CLINICAL INFECTIOUS DISEASES (2012)
The impact of CMV infection on survival in older humans
Graham Pawelec et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Antibodies against the gH/gL/UL128/UL130/UL131 Complex Comprise the Majority of the Anti-Cytomegalovirus (Anti-CMV) Neutralizing Antibody Response in CMV Hyperimmune Globulin
Ashley E. Fouts et al.
JOURNAL OF VIROLOGY (2012)
Decoding Human Cytomegalovirus
Noam Stern-Ginossar et al.
SCIENCE (2012)
Human Cytomegalovirus Escapes a Naturally Occurring Neutralizing Antibody by Incorporating It into Assembling Virions
Kate Manley et al.
CELL HOST & MICROBE (2011)
Polyclonal Immunoglobulins and Hyperimmune Globulins in Prevention and Management of Infectious Diseases
Jennifer L. Hsu et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2011)
Human Cytomegalovirus Infection Is Detected Frequently in Stillbirths and Is Associated With Fetal Thrombotic Vasculopathy
Jenna M. Iwasenko et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
Paul D. Griffiths et al.
LANCET (2011)
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
Francisco M. Marty et al.
LANCET INFECTIOUS DISEASES (2011)
Congenital Cytomegalovirus Infection as a Cause of Sensorineural Hearing Loss in a Highly Immune Population
Aparecida Y. Yamamoto et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Lack of antibodies against the antigen domain 2 epitope of cytomegalovirus (CMV) glycoprotein B is associated with CMV disease after renal transplantation in recipients having the same glycoprotein H serotypes as their donors
K. Ishibashi et al.
TRANSPLANT INFECTIOUS DISEASE (2011)
B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies
Sonja Poetzsch et al.
PLOS PATHOGENS (2011)
HCMV Spread and Cell Tropism are Determined by Distinct Virus Populations
Laura Scrivano et al.
PLOS PATHOGENS (2011)
Extensive Genome-Wide Variability of Human Cytomegalovirus in Congenitally Infected Infants
Nicholas Renzette et al.
PLOS PATHOGENS (2011)
In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246
Peter Lischka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Enzyme-Linked Immunosorbent Assay for Measurement of Cytomegalovirus Glycoprotein B Antibody in Serum
Daniel J. Hackett et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture
Derrick J. Dargan et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Isolation of Human Monoclonal Antibodies That Potently Neutralize Human Cytomegalovirus Infection by Targeting Different Epitopes on the gH/gL/UL128-131A Complex
Annalisa Macagno et al.
JOURNAL OF VIROLOGY (2010)
Antibody discovery via multiplexed single cell characterization
William D. Harriman et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients
Ellen J. Collarini et al.
JOURNAL OF IMMUNOLOGY (2009)
Vaccine Prevention of Maternal Cytomegalovirus Infection
Robert F. Pass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Valganciclovir for Cytomegalovirus Prevention in Solid Organ Transplant Patients: An Evidence-Based Reassessment of Safety and Efficacy
Andre C. Kalil et al.
PLOS ONE (2009)
Germline V-genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus
Christy A. Thomson et al.
EMBO JOURNAL (2008)
Detection of cytomegalovirus, parvovirus B19 and herpes simplex viruses in cases of intrauterine fetal death: Association with pathological findings
Garyfallia Syridou et al.
JOURNAL OF MEDICAL VIROLOGY (2008)
Resolution of hydrops secondary to cytomegalovirus after maternal and fetal treatment with human cytomegalovirus hyperimmune globulin
Katherine Moxley et al.
OBSTETRICS AND GYNECOLOGY (2008)
Treatment of second trimester fetal cytomegalovirus infection with maternal hyperimmune globulin
Kenneth J. Moise et al.
PRENATAL DIAGNOSIS (2008)
Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells
Brent J. Ryckman et al.
JOURNAL OF VIROLOGY (2008)
CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis
Nikolaos Bonaros et al.
CLINICAL TRANSPLANTATION (2008)
Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease
Renato La Torre et al.
CLINICAL INFECTIOUS DISEASES (2006)
Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis
E Maidji et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism
D Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Passive immunization during pregnancy for congenital cytomegalovirus infection
G Nigro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Binding characteristics determine the neutralizing potential of antibody fragments specific for antigenic domain 2 on glycoprotein B of human cytomegalovirus
J Lantto et al.
VIROLOGY (2003)
HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial
DA Jabs et al.
AIDS (2002)
Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus
M Sester et al.
JOURNAL OF VIROLOGY (2002)
Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: Implications for transmission and pathogenesis
S Fisher et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
